India to Kenya: Cabozantinib Export Trade Route
India has recorded 13 verified shipments of Cabozantinib exported to Kenya, representing a combined trade value of $3.8K USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $289 USD. The leading Indian exporter is SPECIALITY MEDICINES PRIVATE LIMITED, which accounts for 31% of total export value with 3 shipments worth $1.2K USD. On the buying side, To The Order is the largest importer in Kenya with $1.2K USD in purchases. The top 3 suppliers — SPECIALITY MEDICINES PRIVATE LIMITED, R S SURGIPHARM PRIVATE LIMITED, R.S. SURGIPHARM PRIVATE LIMITED — together control 79% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Kenya Cabozantinib corridor is one of India's established pharmaceutical export routes, with 13 shipments documented worth a combined $3.8K USD. The route is dominated by SPECIALITY MEDICINES PRIVATE LIMITED, which alone accounts for roughly 31% of all export value, reflecting the consolidated nature of India's cabozantinib manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $289 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with cabozantinib's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 10.2%, placing it at rank #4 among India's top cabozantinib export destinations globally.
On the import side, key buyers of Indian cabozantinib in Kenya include To The Order, TO, TO THE ORDER and 2 others. To The Order is the single largest importer with 3 shipments valued at $1.2K USD.
Route Characteristics
- Average transit22 days
- Peak seasonQ1
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#4
- Annual growth+10.2%
- Demand growth+10.8%
- Regulatory ease86/100
Top 10 Indian Cabozantinib Exporters to Kenya
Showing top 10 of 5 Indian suppliers exporting Cabozantinib to Kenya, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SPECIALITY MEDICINES PRIVATE LIMITED Avg $391 per shipment | 3 | $1.2K | 31.2% |
| 2 | R S SURGIPHARM PRIVATE LIMITED Avg $270 per shipment | 4 | $1.1K | 28.7% |
| 3 | R.S. SURGIPHARM PRIVATE LIMITED Avg $180 per shipment | 4 | $722 | 19.2% |
| 4 | 3S CORPORATION Avg $465 per shipment | 1 | $465 | 12.4% |
| 5 | GENETEC LIFESCIENCES Avg $317 per shipment | 1 | $317 | 8.4% |
This table shows the top 10 of 5 Indian companies exporting cabozantinib to Kenya, ranked by total trade value. The listed exporters are: SPECIALITY MEDICINES PRIVATE LIMITED, R S SURGIPHARM PRIVATE LIMITED, R.S. SURGIPHARM PRIVATE LIMITED, 3S CORPORATION, GENETEC LIFESCIENCES. SPECIALITY MEDICINES PRIVATE LIMITED is the dominant supplier with 3 shipments worth $1.2K USD, giving it a 31% market share. The top 3 suppliers together account for 79% of the total trade value on this route.
Top 10 Cabozantinib Importers in Kenya
Showing top 10 of 5 known buyers in Kenya receiving Cabozantinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian cabozantinib in Kenya include To The Order, TO, TO THE ORDER , FOR THE ORDER OF, TO THE ORDER OF. The largest importer is To The Order, accounting for $1.2K USD across 3 shipments — representing 31% of all cabozantinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | To The Order | 3 | $1.2K | 31.2% |
| 2 | TO | 5 | $1.0K | 27.6% |
| 3 | TO THE ORDER | 3 | $765 | 20.4% |
| 4 | FOR THE ORDER OF | 1 | $465 | 12.4% |
| 5 | TO THE ORDER OF | 1 | $317 | 8.4% |
Top 10 Cabozantinib Formulations Imported by Kenya
Showing top 10 of 12 product formulations shipped on the India to Kenya Cabozantinib route, ranked by trade value
Kenya imports a wide range of cabozantinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — REWARD ITEM HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE CABOZANTINIB 60MGFOR INJECTION CAZANAT 60MG — accounts for $734 USD across 1 shipments. There are 12 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | REWARD ITEM HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE CABOZANTINIB 60MGFOR INJECTION CAZANAT 60MG | 1 | $734 | 19.5% |
| 2 | CABOZANTINIB 60 MG TABS IP (TOTAL QTY 10PACK) | 1 | $465 | 12.4% |
| 3 | HARMLESS MEDICINES INJECATABLE AND TABLETS CABOZANTINIB 40MG TAB 1X30 | 2 | $425 | 11.3% |
| 4 | HARMLESS MEDICINES INJECATABLE AND TABLETS CABOZANTINIB 60MG TAB 1X30 | 1 | $340 | 9.0% |
| 5 | (HARMLESS MEDICINES INJECATABLE AND TABLETS) CABOZANTINIB TABLETS 60MG | 1 | $327 | 8.7% |
| 6 | MEDICINE FOR HUMAN USE CABOZANTINIB TABLETS 60 MG (HSN:30049099) BRAND:CAZANAT 60 MG MFG:NATCO PCK:TAB | 1 | $317 | 8.4% |
| 7 | HARMLESS MEDICINES INJECATABLE AND TABLETS Cabozantinib Tablets 60mg 1x30 | 1 | $315 | 8.4% |
| 8 | REWARD ITEM HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE CABOZANTINIB 40MGFOR INJECTION CAZANAT 40MG | 1 | $294 | 7.8% |
| 9 | (HARMLESS MEDICINES FOR INJECTABLEAND CAPSULES AND TABLETS) CABOZANTINIB TABLETS 60MG (UNIT PACK: 1X30) | 1 | $247 | 6.6% |
| 10 | REWARD ITEM HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE CABOZANTINIB 20MGFOR INJECTION CAZANAT 20MG | 1 | $147 | 3.9% |
Showing top 10 of 12 Cabozantinib formulations imported by Kenya on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 82%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 6 shipments. Transit time averages 22 days by sea.
Market Dynamics
India's cabozantinib exports to Kenya are driven primarily by a handful of large-scale manufacturers. SPECIALITY MEDICINES PRIVATE LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SPECIALITY MEDICINES PRIVATE LIMITED, R S SURGIPHARM PRIVATE LIMITED, R.S. SURGIPHARM PRIVATE LIMITED — together account for 79% of total trade value on this route. The average shipment value of $289 USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as cabozantinib 60 mg tabs ip (total qty 10pack) and harmless medicines injecatable and tablets cabozantinib 40mg tab 1x30, suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, To The Order is the largest importer with 3 shipments worth $1.2K USD — representing 31% of all cabozantinib imports from India on this route.
Route Statistics
- Trade Volume
- $3.8K
- Avg. Shipment
- $289
- Suppliers
- 5
- Buyers
- 5
- Transit (Sea)
- ~22 days
- Annual Growth
- +10.2%
Related Analysis
Other Cabozantinib Routes
Unlock the Full India to Kenya Cabozantinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 13 shipments on this route.
Frequently Asked Questions — India to Kenya Cabozantinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Cabozantinib to Kenya?
The leading Indian exporters of Cabozantinib to Kenya are SPECIALITY MEDICINES PRIVATE LIMITED, R S SURGIPHARM PRIVATE LIMITED, R.S. SURGIPHARM PRIVATE LIMITED. SPECIALITY MEDICINES PRIVATE LIMITED holds the largest market share at approximately 31% of total trade value on this route.
Q What is the total value of Cabozantinib exports from India to Kenya?
India exports Cabozantinib to Kenya worth approximately $3.8K USD across 13 recorded shipments. The average value per shipment is $289 USD.
Q Which ports does India use to ship Cabozantinib to Kenya?
The most active port of origin is SAHAR AIR with 6 shipments. Indian exporters primarily use sea freight for this route, with 82% of shipments going by sea and 28% by air.
Q How long does shipping take from India to Kenya for Cabozantinib?
The average transit time for Cabozantinib shipments from India to Kenya is approximately 22 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Kenya Cabozantinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 10.2% with demand growth tracking at 10.8%. The route is ranked #4 among India's top Cabozantinib export destinations globally.
Q How many suppliers are active on the India to Kenya Cabozantinib route?
There are currently 5 active Indian suppliers exporting Cabozantinib to Kenya. The market is moderately concentrated with SPECIALITY MEDICINES PRIVATE LIMITED accounting for 31% of total shipment value.
Q Who are the main importers of Cabozantinib from India in Kenya?
The leading importers of Indian Cabozantinib in Kenya include To The Order, TO, TO THE ORDER , FOR THE ORDER OF, TO THE ORDER OF. To The Order is the largest buyer with 3 shipments worth $1.2K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Kenya export trade corridor identified from Indian Customs (DGFT) records for Cabozantinib.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 5 importers in Kenya matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 13 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
13 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists